Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Analytical Validation of a Psychiatric Pharmacogenomic Test
Michael Jablonski, Nina King, Yongbao Wang, et al.
Personalized Medicine (2018) Vol. 15, Iss. 3, pp. 189-197
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study
John F. Greden, Sagar V. Parikh, Anthony J. Rothschild, et al.
Journal of Psychiatric Research (2019) Vol. 111, pp. 59-67
Open Access | Times Cited: 268
Treatment-Resistant Depression Revisited: A Glimmer of Hope
Angelos Halaris, Emilie Sohl, Elizabeth A. Whitham
Journal of Personalized Medicine (2021) Vol. 11, Iss. 2, pp. 155-155
Open Access | Times Cited: 70
Pharmacogenomics in treatment of depression and psychosis: an update
Marin M. Jukić, F. Milosavljević, Espen Molden, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 12, pp. 1055-1069
Open Access | Times Cited: 42
A Randomized Controlled Trial of Combinatorial Pharmacogenetics Testing in Adolescent Depression
Jennifer L. Vande Voort, Scott S. Orth, Julia Shekunov, et al.
Journal of the American Academy of Child & Adolescent Psychiatry (2021) Vol. 61, Iss. 1, pp. 46-55
Open Access | Times Cited: 42
Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial
Arun K. Tiwari, Clement C. Zai, C. Anthony Altar, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 37
Multigenetic Pharmacogenomics–Guided Treatment vs Treatment As Usual Among Hospitalized Men With Schizophrenia
Zhewei Kang, Ying Qin, Yutao Sun, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2335518-e2335518
Open Access | Times Cited: 15
The Clinical Utility of Combinatorial Pharmacogenomic Testing for Patients with Depression: A Meta-Analysis
Lisa Brown, Oliver Vranjkovic, James Li, et al.
Pharmacogenomics (2020) Vol. 21, Iss. 8, pp. 559-569
Open Access | Times Cited: 33
Considerations When Applying Pharmacogenomics to Your Practice
Wayne T. Nicholson, Christine M. Formea, Eric T. Matey, et al.
Mayo Clinic Proceedings (2020) Vol. 96, Iss. 1, pp. 218-230
Open Access | Times Cited: 32
Comparing sensitivity to change using the 6-item versus the 17-item Hamilton depression rating scale in the GUIDED randomized controlled trial
Boadie W. Dunlop, Sagar V. Parikh, Anthony J. Rothschild, et al.
BMC Psychiatry (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 27
Nucleic acid sample preparation techniques for bead-based suspension arrays
Sherry Dunbar
Methods (2023) Vol. 219, pp. 22-29
Open Access | Times Cited: 8
Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder
Richard C. Shelton, Sagar V. Parikh, Rebecca Law, et al.
Psychiatry Research (2020) Vol. 290, pp. 113017-113017
Open Access | Times Cited: 22
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression
Brent P. Forester, Sagar V. Parikh, Sara L. Weisenbach, et al.
American Journal of Geriatric Psychiatry (2020) Vol. 28, Iss. 9, pp. 933-945
Open Access | Times Cited: 21
The Utility of Pharmacogenetic-Guided Psychotropic Medication Selection for Pediatric Patients: A Retrospective Study
Merlin Ariefdjohan, Yee Ming Lee, Danielle L. Stutzman, et al.
Pediatric Reports (2021) Vol. 13, Iss. 3, pp. 421-433
Open Access | Times Cited: 11
Clinical Implications of Combinatorial Pharmacogenomic Tests Based on Cytochrome P450 Variant Selection
M. Sayer, Ashley Duche, Trang Jenny Tran Nguyen, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 11
Analytical validation of GenoPharm a clinical genotyping open array panel of 46 pharmacogenes inclusive of variants unique to people of African ancestry
Comfort Kanji, Bianza Tinotenda Mbavha, Collen Masimirembwa, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0292131-e0292131
Open Access | Times Cited: 4
Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression
Anthony J. Rothschild, Sagar V. Parikh, Daniel Hain, et al.
Psychiatry Research (2020) Vol. 296, pp. 113649-113649
Open Access | Times Cited: 11
Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.

PubMed (2021) Vol. 21, Iss. 13, pp. 1-214
Closed Access | Times Cited: 10
Liver Enzyme CYP2D6 Gene and Tardive Dyskinesia
Justin Y. Lu, Arun K. Tiwari, Natalie Freeman, et al.
Pharmacogenomics (2020) Vol. 21, Iss. 15, pp. 1065-1072
Open Access | Times Cited: 6
Prevalence of predicted gene-drug interactions for antidepressants in the treatment of major depressive disorder in the Precision Medicine in Mental Health Care Study
Christine M. Ramsey, Kevin G. Lynch, Michael E. Thase, et al.
Journal of Affective Disorders (2021) Vol. 282, pp. 1272-1277
Closed Access | Times Cited: 5
Combinatorial pharmacogenomic algorithm is predictive of sertraline metabolism in patients with major depressive disorder
Sagar V. Parikh, Rebecca Law, Daniel Hain, et al.
Psychiatry Research (2021) Vol. 308, pp. 114354-114354
Open Access | Times Cited: 5
Literature Review Concerning the Challenges of Implementing Pharmacogenetics in Primary Care Practice
Mohamed S Omer
Cureus (2020)
Open Access | Times Cited: 4
Real-world experience of using combinatorial pharmacogenomic test in children and adolescents with depression and anxiety
Anjali Dagar, Suneela Cherlopalle, Veena Ahuja, et al.
Journal of Psychiatric Research (2021) Vol. 146, pp. 83-86
Closed Access | Times Cited: 4
Early adoption of pharmacogenetic testing for veterans prescribed psychotropic medications
Leland E. Hull, Catherine Chanfreau‐Coffinier, Sony Tuteja, et al.
Pharmacogenomics (2019) Vol. 20, Iss. 11, pp. 781-789
Open Access | Times Cited: 3
Pharmacogenomic Profiling of Pediatric Patients on Psychotropic Medications in an Emergency Department
Pallavi Ghosh, Jesse Martinez, Nipam Shah, et al.
Pediatric Emergency Care (2022) Vol. 39, Iss. 1, pp. 6-12
Open Access | Times Cited: 2
Response to: Goldberg et al. and Severance et al. Letters to the Editor: The clinical significance of improving remission over standard of care – The reality of treatment resistant-based therapies
John F. Greden, Sagar V. Parikh, Anthony J. Rothschild, et al.
Journal of Psychiatric Research (2019) Vol. 114, pp. 211-213
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top